Linde legal chief Guillermo Bichara sells 9,350 shares
Linde's chief legal officer's option exercise included withholding for the exercise price and taxes, plus a separate sale of 9,350 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Linde plc Executive Vice President and Chief Legal Officer Guillermo Bichara exercised options for 26,155 ordinary shares on November 2, 2026, at an exercise price of $173.13 per share. The same-day transactions also included 16,805 shares withheld for the exercise price and tax withholdings and a sale of 9,350 shares at a weighted average price of $518.911 per share. No Rule 10b5-1 plan is reported. Remaining option positions include 40,100 shares exercisable at $118.71, expiring February 28, 2027, and 38,800 at $154.00, expiring February 27, 2028.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Bichara Guillermo
Role
Exec VP & Chief Legal Officer
Sold
9,350 shs ($4.85M)
Approx. gross sale proceeds
$4.85M
Approx. exercise cost
$4.53M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) F18 | 26,155 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 26,155 | $173.13 | $4.53M |
| Exercise Price or Tax Liability | Ordinary Shares F1 | 16,805 | $518.685 | $8.72M |
| Sale | Ordinary Shares F2 | 9,350 | $518.911 | $4.85M |
| Holding | Stock Options (right to buy) F3 | -- | -- | -- |
| Holding | Stock Options (right to buy) F4 | -- | -- | -- |
| Holding | Stock Options (right to buy) F5 | -- | -- | -- |
| Holding | Restricted Stock Units F6 | -- | -- | -- |
| Holding | Stock Options (right to buy) F7 | -- | -- | -- |
| Holding | Restricted Stock Units F8, F9 | -- | -- | -- |
| Holding | Stock Options (right to buy) F10 | -- | -- | -- |
| Holding | Restricted Stock Units F11 | -- | -- | -- |
| Holding | Stock Options (right to buy) F12 | -- | -- | -- |
| Holding | Restricted Stock Units F13 | -- | -- | -- |
| Holding | Stock Options (right to buy) F14 | -- | -- | -- |
| Holding | Deferred Stock Units F15, F16 | -- | -- | -- |
| Holding | Stock Options (right to buy) F17 | -- | -- | -- |
| Holding | Stock Options (right to buy) F4 | -- | -- | -- |
| Holding | Stock Options (right to buy) F18 | -- | -- | -- |
| Holding | Restricted Stock Units F11 | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 207,958 contracts (Direct);
Ordinary Shares — 44,275.538 shares (Direct);
Restricted Stock Units — 6,626 contracts (Direct);
Deferred Stock Units — 852.647 contracts (Direct);
Ordinary Shares — 2,944.983 shares (Indirect, 401(k))
Footnotes (18)
- F1. Ordinary shares withheld to cover exercise price and tax withholdings.
- F2. The price reported is the weighted average sale price. The sale prices ranged from 518.60 to 519.11. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- F3. This option vested over three years in three consecutive equal annual installments beginning on February 27, 2019.
- F4. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
- F5. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
- F6. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
- F7. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
- F8. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
- F9. Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
- F10. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
- F11. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
- F12. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
- F13. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
- F14. This option vested over three years in three consecutive equal annual installments beginning on February 28, 2018.
- F15. Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
- F16. Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
- F17. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
- F18. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
Key Figures
Options exercised: 26,155 shares
Exercise price: $173.13 per share
Ordinary shares acquired: 26,155 shares
+4 more
7 metrics
Options exercised
26,155 shares
Exercise on November 2, 2026
Exercise price
$173.13 per share
Options exercised on November 2, 2026
Ordinary shares acquired
26,155 shares
Exercise on November 2, 2026
Shares withheld
16,805 shares
Withheld for exercise price and tax withholdings on November 2, 2026
Shares sold
9,350 shares
Sale on November 2, 2026
Weighted average sale price
$518.911 per share
Sale on November 2, 2026
Individual sale price range
$518.60 to $519.11 per share
Reported range for the November 2, 2026 sale
Key Terms
weighted average sale price, exercise price, Restricted Stock Units, Deferred stock units
4 terms
weighted average sale price financial
"The price reported is the weighted average sale price."
exercise price financial
"Ordinary shares withheld to cover exercise price and tax withholdings."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Restricted Stock Units financial
"Restricted Stock Units that will vest in full and payout"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Deferred stock units financial
"Deferred stock units acquired under the Linde Compensation Deferral Plan"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many LIN stock options did Guillermo Bichara exercise?
Guillermo Bichara exercised options covering 26,155 ordinary shares on November 2, 2026, at an exercise price of $173.13 per share. The transactions also show 16,805 shares withheld to cover the exercise price and tax withholdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
